Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSolGold Regulatory News (SOLG)

  • This share is currently suspended. It was suspended at a price of 27.95
  • There is currently no data for SOLG

Form 8.3 SOLGOLD PLC

31 Dec 2025 08:58

RNS Number : 2920N
Barclays PLC
31 December 2025
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

SOLGOLD PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

30 Dec 2025

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

1p ordinary

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

34,125,740

1.13%

2,578,706

0.09%

(2)

Cash-settled derivatives:

 

 

 

 

 

 

 

 

1,425,751

0.05%

34,125,740

1.13%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

35,551,491

1.18%

36,704,446

1.22%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

1p ordinary

Purchase

11,828,176

0.2764 GBP

1p ordinary

Purchase

9,700,000

0.2761 GBP

1p ordinary

Purchase

1,367,143

0.2765 GBP

1p ordinary

Purchase

814,735

0.2762 GBP

1p ordinary

Purchase

763,162

0.2763 GBP

1p ordinary

Purchase

374,259

0.2760 GBP

1p ordinary

Purchase

8

0.2770 GBP

1p ordinary

Sale

2,043,314

0.2765 GBP

1p ordinary

Sale

694,673

0.2763 GBP

1p ordinary

Sale

684,876

0.2762 GBP

1p ordinary

Sale

75,840

0.2760 GBP

1p ordinary

Sale

8,876

0.2770 GBP

1p ordinary

Sale

8,868

0.2767 GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

1p ordinary

SWAP

Decreasing Short

104,532

0.2754 GBP

1p ordinary

SWAP

Decreasing Short

590,000

0.2764 GBP

1p ordinary

SWAP

Decreasing Short

24,691

0.2765 GBP

1p ordinary

SWAP

Increasing Short

9,700,000

0.2761 GBP

1p ordinary

SWAP

Increasing Short

1,289,677

0.2762 GBP

1p ordinary

SWAP

Increasing Short

307,607

0.2763 GBP

1p ordinary

SWAP

Increasing Short

10,405,455

0.2764 GBP

1p ordinary

SWAP

Increasing Short

540,505

0.2765 GBP

1p ordinary

CFD

Increasing Long

163,715

0.2763 GBP

1p ordinary

CFD

Increasing Long

37,359

0.2764 GBP

1p ordinary

CFD

Decreasing Long

8,089

0.2765 GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercise

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i) the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

31 Dec 2025

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETPKDBPFBDKOBN
Date   Source Headline
17th Sep 20257:00 amRNSDrilling Reports at Tandayama
1st Sep 20257:00 amRNSTransition of Corporate Domicile
19th Aug 20254:44 pmRNS-RAnnounces Canaccord Genuity Engagement
15th Aug 20257:00 amRNSExceptional Near-Surface Intercepts at Tandayama
31st Jul 20257:00 amRNSDirector/PDMR Shareholding
28th Jul 20257:00 amRNSMultiple High-Grade Intervals at Tandayama-América
21st Jul 20257:00 amRNS$33.3M Received from Franco-Nevada & OR Royalties
17th Jul 20257:00 amRNSProject Execution Plan
10th Jul 20257:00 amRNSUS$33.3M Second Advance Under Stream Financing
4th Jun 20253:53 pmRNSDirector/PDMR Shareholding
2nd Jun 20257:00 amRNSVoluntary Delisting from Toronto Stock Exchange
16th May 20257:00 amRNSQ3 Financial Report and Quarterly MD&A
12th May 20257:03 amRNSEnvironmental Licence Granted for Porvenir Project
1st May 20257:00 amRNSCascabel Amended Investment Protection Agreement
15th Apr 20256:14 pmRNSDirector/PDMR Shareholding
15th Apr 20253:10 pmRNSSolGold Early Production Open Pit Strategy
27th Mar 20252:37 pmRNSHolding(s) in Company
26th Mar 20255:56 pmRNSHolding(s) in Company
24th Mar 20257:03 amRNSJiangxi Copper Investment Conditions Satisfied
14th Mar 20257:00 amRNSAppointment of Senior Independent Director
12th Mar 20258:01 amRNSFurther Investment from Jiangxi Copper
4th Mar 20258:00 amRNSNew CEO and Chair, and Re-Setting Company Strategy
21st Feb 202510:15 amRNSStatement re Litigation with Ex-CEO
14th Feb 20257:00 amRNSQ2 Financial Report and Quarterly MD&A
14th Jan 20256:11 pmRNSBlock Listing Six Monthly Return
5th Dec 20244:58 pmRNSResult of AGM
28th Nov 20246:00 pmRNSShareholder Update on Voting Process
18th Nov 20247:00 amRNSKey Milestones and Outlook for the Year Ahead
15th Nov 20247:13 amRNSQ1 Financial Report and Quarterly MD&A
7th Nov 20242:39 pmRNSNotice of AGM
4th Nov 20247:00 amRNSGeotechnical Investigations Commence at Cascabel
28th Oct 20247:00 amRNSCascabel Project Update
16th Oct 20247:00 amRNSCompany Update
27th Sep 20247:00 amRNSRelease of FY24 Annual Report and Accounts
16th Sep 20247:00 amRNSCompany Update
14th Aug 20244:57 pmRNSDirector/PDMR Shareholding
14th Aug 20247:00 amRNSCascabel Project Update
12th Aug 20243:30 pmRNSDirector/PDMR Shareholding
1st Aug 20246:20 pmRNSDirector/PDMR Shareholding
26th Jul 202412:08 pmRNSBlock Listing Six Monthly Return
18th Jul 20245:25 pmRNSPDMR Dealing
15th Jul 20247:00 amRNSUS$750M Financing Package for the Cascabel Project
25th Jun 20244:15 pmRNSFinancing Update
6th Jun 20247:00 amRNSExploitation Contract for Cascabel Project
16th May 20247:00 amRNSThird-Quarter Financial Report and Quarterly MD&A
14th May 20247:00 amRNSKey Financial Developments
15th Apr 20245:17 pmRNSDirector/PDMR Shareholding
12th Apr 20244:00 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSBlanca-Nieves Project Update
12th Mar 20247:00 amRNSPre-Feasibility Study Technical Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.